novo nordisk insulin - Search News

FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic

NBC New York · 1d

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders

The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for compounding pharmacies to make copies of Ozempic and Wegovy.

USA TODAY on MSN · 1d

Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, a declaration that will curtail widespread sales of cheaper copies made by compounding pharmacies.

14hon MSN

Why Novo Nordisk A/S (NVO) Surged On Friday?

We recently published a list of Five Chinese Firms Dominate Friday’s Top 10 Gainers. In this article, we are going to take a ...

1hon MSN

Lilly, Novo dominance to continue as TD Cowen lifts 2030 GLP-1 sales forecast by 38%

Eli Lilly (LLY) and Novo Nordisk (NVO) to dominate as TD Cowen lifts 2030 sales forecast for GLP-1 class of obesity/ diabetes ...

Bloomberg on MSN1d

Novo’s Ozempic Shortage Is Declared Over, Hitting Copycats

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...

Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

2d

Novo Nordisk Prices In Too Few New Patients For GLP-1 Currently

Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...

6don MSN

2 Important Insights From Novo Nordisk's Earnings Call

Novo Nordisk has been looking to diversify its lineup in recent years, and is developing medicines in other fields. The ...

3d

Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity

Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results